Partner with us
Studies
/
Genetic Toxicity Studies of the Ketogenic Ester Bis Hexanoyl (R)-1,3-Butanediol
Human other
2021

Genetic Toxicity Studies of the Ketogenic Ester Bis Hexanoyl (R)-1,3-Butanediol

Key finding
BH-BD was negative in all three genetic toxicity tests, the bacterial reverse mutation test, the in vitro human cell micronucleus test and the in vivo rat micronucleus test.
What the study did

This series of studies assessed the genetic toxicity of the ketone ester bis hexanoyl (R)-1,3-butanediol (BH-BD) under OECD guidelines and Good Laboratory Practices. There was no evidence of mutagenic activity in bacterial reverse mutation tests at doses up to 5,000 µg/plate, with or without metabolic activation. BH-BD did not significantly increase micronuclei in human TK6 cells at concentrations up to 100 µg/mL, nor micronucleated polychromatic erythrocytes in Sprague Dawley rats. BH-BD was concluded to be negative in all 3 tests.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB